General Medicines, Commercial Director, Menopause

Role: Senior leader overseeing Pfizer's Menopause Portfolio strategy and commercialization within the PAVE initiative. Responsibilities: develop and execute portfolio and brand strategies based on customer insights, drive cross-functional alignment, manage external partnerships (notably with Indegene), oversee content development and compliance, prioritize initiatives, and deliver measurable commercial results. Act as a key stakeholder connector to optimize resource allocation and cross-team collaboration, while leading with strong judgment and high standards. Qualifications: BA/BS with ≥8 years, MBA/MS with ≥7 years, PhD/JD with ≥5 years, or MD/DVM with ≥4 years in pharmaceutical or healthcare sectors. Must have experience in brand management, pharmaceutical strategy development, data analysis, stakeholder engagement, project management, and familiarity with regulatory and GxP requirements. Preferred skills include leadership, influence, communication, and patient-centric approaches. High-Value: Managing a ~$400M revenue portfolio of hormone therapy brands (Duavee, Estring, Premarin, Prempro, PVC), targeting menopausal women, with a focus on market strategy, partnership models, and compliance. Work setup: Hybrid in Collegeville, PA, and Lake Forest, IL with ~10% travel. The role emphasizes strategic leadership, cross-functional influence, and market engagement in a complex regulatory environment.